Accéder au contenu
Merck

Preparation and properties of new co-crystals of ibandronate with gluco- or galactopyranoside derivatives.

Molecules (Basel, Switzerland) (2010-12-15)
Zbynek Oktabec, Jiri Kos, Zuzana Mandelova, Lenka Havelkova, Tomas Pekarek, Anna Rezacova, Lukas Placek, Marcela Tkadlecova, Jaroslav Havlicek, Jiri Dohnal, Josef Jampílek
RÉSUMÉ

Mixtures of ibandronate monosodium salt with eleven gluco- and/or galacto-pyranoside derivatives as counterions were designed to prepare co-crystals with improved intestinal absorption. In general, gastrointestinal absorption of bisphosphonates after oral administration is approximately 1%. Co-crystals were generated by means of thermodynamically and/or kinetically controlled crystallization processes. Seventy-seven prepared samples were analyzed by means of FT-NIR, FT-Raman spectrometry and solid state NMR spectroscopy. New entities of ibandronate monosodium salt with phenyl-β-D-galactopyranoside were found and characterized. The absorption of these potential new co-crystals was investigated by means of PAMPA experiments. In the present study the relationships between the chemical structures of the studied compounds required for co-crystal generation are discussed.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Phenyl-β-D-galactopyranoside, ≥98% (TLC)